Margarita Alegría

Margarita Alegría, Ph.D., is the Chief of the Disparities Research Unit at Massachusetts General Hospital, and a Professor in the Departments of Medicine and Psychiatry at Harvard Medical School. Dr. Alegría is currently the PI of four National Institutes of Health (NIH)-funded research studies: International Latino Research Partnership; Effects of Social Context, Culture and Minority Status on Depression and Anxiety; Building Community Capacity for Disability Prevention for Minority Elders; and Mechanisms Underlying Racial/Ethnic Disparities in Mental Disorders. She is also the co-PI of a William T. Grant Foundation project, entitled Understanding the Experience of Majority and Minority Status through Photovoice. Dr. Alegría has published over 200 papers, editorials, intervention training manuals, and several book chapters, on topics such as improvement of health care services delivery for diverse racial and ethnic populations, conceptual and methodological issues with multicultural populations, and ways to bring the community’s perspective into the design and implementation of health services.   As an acknowledgement of her contributions to her field, Dr. Alegría has been widely recognized and cited. Among the many awards: the Mental Health Section Award from the American Public Health Association, 2003; the Health Disparities Innovation Award from the National Institute of Minority Health and Health Disparities, 2008; the Carl Taube Award from the American Public Health Association, 2008; the Simon Bolivar Award from the American Psychiatric Association, 2009; and the Award of Excellence from the National Hispanic Science Network on Drug Abuse, 2011. In October 2011, she was elected as a member of the Institute of Medicine. In addition, Dr. Alegría was selected as El Planeta’s (Massachusetts’s largest circulating Spanish-language newspaper) 2013’s Powermeter 100 most influential people for the Hispanic community in Massachusetts.

Robert Angell

Rob started his career at Ernst & Young and has held senior executive positions at several high growth public and privately-owned companies including Managing Director at Accounting Management Solutions, Chief Operating Officer at Zentropy Partners, Chief Financial Officer at Hill Holliday and Chief Administrative Officer at The Parthenon Group. He has also worked as part of the management team at Boston Consulting Group. Rob is on the faculties of Brandeis University and Wheaton College Executive Education. He is a CPA and has degrees from Brown University and New York University.

Jeannie Aschkenasy

Jeannie Aschkenasy, Ph.D. is a licensed clinical psychologist with 30 years of experience working in private practice and in medical settings. Dr. Aschkenasy has been on staff at Rush University Medical Center since 1986. She graduated from Smith College and earned her Ph.D. from Vanderbilt University. In 1998, she co-founded Kids-SHIP, a program that provides pediatric services to homeless children in shelters. Her post-doctoral training was at the Piaget Institute in Geneva, Switzerland, Michael Reese Hospital in Chicago, and the University of Chicago.

Joao Busnello

Dr. Joao Busnello is a board-certified clinical/research psychiatrist who has been on staff at Rush University Medical Center and Chicago Lakeshore Hospital. He has an extensive background in pharmacogenomics (postdoctoral fellowships at the University of Miami and UCLA) and holds a Ph.D. in biochemistry. His residency training in Psychiatry was at the University of Chicago. He has run hospital clinics and been responsible for medical resident training. He is a clinician-scientist with extensive expertise in cross-cultural psychiatry.

Chih-Hung Chang

Chih-Hung Chang, Ph.D. is a Professor of Occupational Therapy and of Medicine at the Washington University School of Medicine in St. Louis. He also holds an Adjunct Professor position at the Graduate Institute of Biostatistics of China Medical University in Taichung, Taiwan. He began graduate work at the University of Chicago in 1988 and received his Ph.D. from the Committee on Research Methodology and Quantitative Psychology of the Department of Psychology in 1995. Dr. Chang is an internationally recognized psychometrician with pioneering expertise in applying item response theory to health-related quality of life and patient-reported outcomes measurement. He also has extensive experience in health information technology. His clinical infometrics discipline is to integrate informatics and psychometrics to improve the quality of care and patient safety.

Yehuda Cohen

Yehuda Cohen has worked as a veteran operations executive for 25+ years. He has implemented numerous licenses, partnerships, and collaborations with hospital systems, technology partners, private and non-profit clinics, federal and state agencies, and national research institutions. He works collaboratively with researchers and research institutions on a variety of federally funded projects as well as international collaborations. He received his BA from Brandeis University and his MBA from the University of Michigan. He is a member of the board of advisors for Guava Group Healthcare Consulting and serves as a Fellow of Brandeis University and is the past president of the University of Michigan Ross Club of Chicago.

Bernie Dyme

Bernie Dyme is a founder of Perspectives, a leading national Employee Assistance Program which he co-founded in 1981. He has used his clinical and systems training at the University of Chicago's School of Social Service Administration to provide consulting services to hundreds of organizations and help them develop a balanced approach between cost savings and safe, healthy, productive workplaces. He is also an active member of more than a dozen professional and community organizations and serves on the Workplace Task Force of the National Action Alliance for Suicide Prevention. He is a licensed clinical social worker (LCSW) in the state of Illinois with a BS from the University of Illinois and a Master's degree from the University of Chicago.

Jan Fawcett

Dr. Jan Fawcett, a graduate of Yale University School of Medicine, was the Stanley Harris, Sr. Chairman of the Department of Psychiatry at Rush Medical College in Chicago for 30 years, before joining the Department of Psychiatry of the University of New Mexico School of Medicine. Dr. Fawcett has pursued a career of research in the treatment of affective disorders and the prevention of suicide since completing his fellowship at the National Institute of Mental Health Clinical Center in 1964. Dr. Fawcett has been awarded the Dr. Jan Fawcett Humanitarian Award by the National Depressive and Manic Depressive Association (now the Depression and Bipolar Support Alliance), and lifetime research awards by the American Association of Suicidology and the American Foundation for Suicide Prevention. He was also presented the Menninger award by the American College of Physicians for his research in mental health in 2000. In 2005, Dr. Fawcett shared the Falcone Prize for affective disorders research from the National Alliance for Research in Schizophrenia and Depression (NARSAD). He was the principal investigator of the “Recurrent Depression Prevention with Medication and Cognitive Behavioral Therapy” project, a five-year study funded by NIMH at Rush Medical Center in collaboration with investigators at Vanderbilt and the University of Pennsylvania. He is a co-author of the APA Practice Guidelines on the assessment and management of suicidal patients and is the chairperson of the DSM-5 Mood Disorders Task Force from 2007-2012. Dr. Fawcett has always maintained an active clinical practice focusing on patients with treatment-resistant major affective disorders.

Ellen Frank

Ellen Frank, Ph.D. was formerly a Distinguished Professor of Psychiatry and Professor of Psychology at the University of Pittsburgh School of Medicine and Director of the Depression and Manic Depression Prevention program at Western Psychiatric Institute and Clinic. An expert in mood disorders and their treatment, Dr. Frank was Chair of the Food and Drug Administration Psychopharmacologic Drugs Advisory Panel. She also is a former member of the U.S. National Advisory Mental Health Council. She recently completed her service on the Mood Disorders Workgroup of the American Psychiatric Association Task Force on DSM-5. She is an Honorary Fellow of the American Psychiatric Association. In 1999, Dr. Frank was elected to the National Academy of Sciences National Academy of Medicine. Dr. Frank has published over 425 peer-reviewed publications in psychiatric journals. A graduate of Vassar College, Frank earned a master’s degree in English at Carnegie Mellon University and a doctorate in psychology at the University of Pittsburgh.

Robert Gibbons

Robert D. Gibbons, Ph.D. is the Blum-Riese Professor and Pritzker Scholar at the University of Chicago. He has appointments in the Departments of Medicine and Public Health Sciences. He also directs the Center for Health Statistics. Professor Gibbons is a Fellow of the American Statistical Association, a member of the International Statistical Institute, and a member of the National Academy of Medicine of the National Academy of Sciences. He has authored more than 300 peer-reviewed scientific papers and 6 books. His statistical work spans the areas of longitudinal data analysis, item response theory, environmental statistics, and drug safety and has led to thousands of applications in the biological and social sciences. Professor Gibbons has received lifetime achievement awards from the American Statistical Association, the American Public Health Association and Harvard University. He is a founder of the Mental Health Statistics section of the American Statistical Association. He received his Ph.D. at the University of Chicago in 1981.

John M. Kane

John M. Kane, MD, is Senior Vice President for Behavioral Health Services at Northwell Health in New Hyde Park, New York. He is Professor and Chairman of Psychiatry at The Hofstra Northwell School of Medicine. He also serves as Chairman of Psychiatry at The Zucker Hillside Hospital in Glen Oaks, New York. Dr. Kane earned his medical degree from New York University in New York, New York, and completed his internship and residency in Psychiatry at The Zucker Hillside Hospital. He is a Diplomate of the American Board of Psychiatry and Neurology. Dr. Kane is the recipient of many awards, including: the Lieber Prize; The APA’s Kempf Award, the Gralnick Award and Foundations Prize; the New York State Office of Mental Health Lifetime Achievement Award; and The Dean Award from the American College of Psychiatrists. He has served as President of the American Society of Clinical Psychopharmacology, the Psychiatry Research Society and the Schizophrenia International Research Society. Dr. Kane has been the principal investigator for research projects focusing on schizophrenia psychobiology, treatment and recovery, as well as improving quality and cost of care. He is the author of over 400 peer-reviewed papers and serves on the editorial boards of numerous journals.

David Kupfer

Dr. David Kupfer was the former Thomas Detre Professor of Psychiatry and Neuroscience at the University of Pittsburgh School of Medicine. Between 1983 and 2009, he was the Chair of the Department of Psychiatry at the University of Pittsburgh School of Medicine and Director of Research at Western Psychiatric Institute and Clinic. Dr. Kupfer has over 30 years of experience in the assessment and treatment of mood disorders, the relationship of biological abnormalities to mood disturbance, and the dissemination of treatments based on these findings. In addition, Dr. Kupfer has had a long-standing interest in, and experience with, research on the lifestyle correlates of sleep, mood, and performance in the normal populations as well as individuals with mood disorders. In recognition of his contributions to the field, Dr. Kupfer has been the recipient of numerous awards and honors, and he is the Founding President of the International Society of Bipolar Disorders. Dr. Kupfer served as Chair of the American Psychiatric Association DSM-5 Task Force, a role that reflects a long-standing interest in using empirical evidence to inform the diagnosis of psychiatric disorders. He is an elected member of the National Academy of Medicine of the National Academy of Sciences.

J. John Mann

J. John Mann MD, is The Paul Janssen Professor of Translational Neuroscience (in Psychiatry and in Radiology) at Columbia University. He is Director of Molecular Imaging and the Neuropathology Division at the New York State Psychiatric Institute and the Department of Psychiatry. Dr. Mann is trained in Psychiatry and Internal Medicine and has a Doctorate in Neurochemistry. His research employs functional brain imaging, neurochemistry, and molecular genetics to probe the causes of depression and suicide. Dr. Mann is the Director of the NIMH Conte Center for the Neuroscience of Mental Disorders, and Past President of the International Academy of Suicide Research and Society of Biological Psychiatry. Dr. Mann has published over 700 papers and edited 10 books on the subjects of the biology and treatment of mood disorders, suicidal behavior, and other psychiatric disorders. In private practice, he specializes in the treatment of mood disorders. College of Psychiatrists.

Tara Moore

Tara Moore, MA, MPH has extensive experience in the development, implementation, and management of clinical and mental health research initiatives for several major health systems. For the past 10 plus years, she has been a project manager in the development, testing, and management of CAT-MHTM. Ms. Moore obtained her Masters in Medical Anthropology and Master of Public Health from Case Western Reserve University.

Paul Pilkonis

Paul Pilkonis' Ph.D. research interests are supported by NIH funding and include assessment and treatment of personality disorders, depression (and its relationship to personality), treatment outcome research, and the application of new quantitative tools to measurement and modeling problems in psychopathology. He has had the privilege of participating in the NIH research enterprise from several perspectives - as an investigator, member and chair of review committees, and scientific advisor at the National Institute of Mental Health (NIMH), giving him firsthand knowledge of federal research policy and administration.

David Weiss

David Weiss, Ph.D. is a leader in the field of computerized adaptive testing (CAT). His expertise includes computerized adaptive testing and psychometric methods in many areas including vocational counseling. He is the author of numerous publications including a chapter on item banking, test development, and test delivery in the Handbook on Testing and Assessment (American Psychological Association). He is the president emeritus of the International Association for Computerized Adaptive Testing and a fellow of the American Psychological Association. He received his Ph.D. from the University of Minnesota where he is a member of the Department of Psychology.

None of the team members’ respective institutions makes any implied endorsement for any of their efforts connected with Adaptive Testing Technologies.